SCHEMBL23179482

SCHEMBL23179482

c1ccc(N(c2ccc(-c3ccc(-c4cccc(-c5ccc6ccccc6c5)c4)cc3)cc2)c2cccc3oc4ccccc4c23)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.39
▸ PLA2G4A P47712 3/20 0.39
▸ PLA2G10 O15496 1/20 0.36
▸ HSD17B1 P14061 1/20 0.36
▸ HSD17B2 P37059 1/20 0.36
▸ PGR P06401 1/20 0.36
▸ ANO1 Q5XXA6 1/20 0.36
▸ ESR1 P03372 3/20 0.35
▸ ESR2 Q92731 3/20 0.35
▸ CYP1A2 P05177 2/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ FYN P06241 1/20 0.33
▸ MAPK3 P27361 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ ABCG2 Q9UNQ0 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23180029 1.00 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL23179112 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL23180349 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL23180300 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL23179119 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL24842288 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL23180663 0.99 PLA2G2A (0.39) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL24841724 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL24841725 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2
SCHEMBL21663952 0.98 PLA2G2A (0.37) PLA2G2APLA2G4APLA2G10HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-05 — — US disclosed
WO-2021060239-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, POU2F1 PLA2G2A 4651/4885PLA2G4A 4762/4885PLA2G10 4458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback